Logo image of SMX

SMX SECURITY MATTERS PLC-A (SMX) Stock Fundamental Analysis

NASDAQ:SMX - Nasdaq - IE000WZ90ZV5 - Common Stock - Currency: USD

1.04  -0.08 (-7.14%)

Premarket: 0.99 -0.05 (-4.81%)

Fundamental Rating

0

Overall SMX gets a fundamental rating of 0 out of 10. We evaluated SMX against 125 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of SMX have multiple concerns. SMX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SMX had negative earnings in the past year.
SMX had a negative operating cash flow in the past year.
SMX Yearly Net Income VS EBIT VS OCF VS FCFSMX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of SMX (-40.88%) is worse than 84.80% of its industry peers.
SMX has a worse Return On Equity (-182.24%) than 88.80% of its industry peers.
Industry RankSector Rank
ROA -40.88%
ROE -182.24%
ROIC N/A
ROA(3y)-14.79%
ROA(5y)N/A
ROE(3y)-62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SMX Yearly ROA, ROE, ROICSMX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -50 -100 -150

1.3 Margins

SMX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SMX Yearly Profit, Operating, Gross MarginsSMX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

SMX has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, SMX has a worse debt to assets ratio.
SMX Yearly Shares OutstandingSMX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 1K 2K 3K 4K
SMX Yearly Total Debt VS Total AssetsSMX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

SMX has an Altman-Z score of -2.54. This is a bad value and indicates that SMX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.54, SMX is doing worse than 87.20% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that SMX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.20, SMX is in line with its industry, outperforming 45.60% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z -2.54
ROIC/WACCN/A
WACCN/A
SMX Yearly LT Debt VS Equity VS FCFSMX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.04 indicates that SMX may have some problems paying its short term obligations.
SMX has a worse Current ratio (0.04) than 99.20% of its industry peers.
A Quick Ratio of 0.04 indicates that SMX may have some problems paying its short term obligations.
With a Quick ratio value of 0.04, SMX is not doing good in the industry: 99.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
SMX Yearly Current Assets VS Current LiabilitesSMX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.62% over the past year.
EPS 1Y (TTM)49.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.18%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SMX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SMX Price Earnings VS Forward Price EarningsSMX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SMX Per share dataSMX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1K -2K -3K -4K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SMX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SMX SECURITY MATTERS PLC-A

NASDAQ:SMX (6/12/2025, 8:00:02 PM)

Premarket: 0.99 -0.05 (-4.81%)

1.04

-0.08 (-7.14%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.36%
Inst Owner Change-97.52%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap4.84M
AnalystsN/A
Price TargetN/A
Short Float %1.16%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4366.17
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.18
FCFYN/A
OCF(TTM)-2.01
OCFYN/A
SpS0
BVpS2.47
TBVpS-8.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.88%
ROE -182.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.79%
ROA(5y)N/A
ROE(3y)-62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 364.41%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -2.54
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-125.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1015.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-926.37%
OCF growth 3YN/A
OCF growth 5YN/A